JiangSu Bicon Pharmaceutical Listed Co operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JiangSu Bicon Pharmaceutical Listed Co with three other
companies in this sector in China:
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
sales of 5.69 billion Chinese Renmimbi [US$900.61 million]
Hubei Jumpcan Pharmaceutical Co Ltd
(5.64 billion Chinese Renmimbi [US$893.13 million]
of which 96%
was Industrial), and
China Medical System Holdings Limited
(5.35 billion Chinese Renmimbi [US$846.72 million]
of which 100%
was Pharmaceutical Products).
During the year ended December of 2017, sales at
JiangSu Bicon Pharmaceutical Listed Co were 5.37 billion Chinese Renmimbi (US$849.75 million).
increase of 44.2%
versus 2016, when the company's sales were 3.72 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at JiangSu Bicon Pharmaceutical Listed Co.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
143.3% in 2017, from
15.28 million Chinese Renmimbi to 37.18 million Chinese Renmimbi.
JiangSu Bicon Pharmaceutical Listed Co also saw significant increases in sales in
New Materials (up 61.5% to 226.56 million Chinese Renmimbi)
Not all segments of JiangSu Bicon Pharmaceutical Listed Co experienced an increase in sales in 2017:
sales of New Energy fell 61.6% to 206.94 million Chinese Renmimbi.